Teachers Advisors’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Teachers Advisors’s Portfolio LOGC Stock Details LOGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$108K	Hold	10,888	–	–	﹤0.01%	2924
2018 Q4	$113K	Buy	+10,888	New	+$132K	﹤0.01%	2940

Other funds holding LOGC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Teachers Advisors's LOGC Position: Q1 2019 in Review

Teachers Advisors held its LogicBio Therapeutics, Inc. Common Stock (LOGC) position steady in Q1 2019 at 10,888 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #2924.

Teachers Advisors first reported a position in LOGC in Q4 2018 and has held it in 2 quarters since. The position peaked at $113K in Q4 2018. 33 funds tracked by Wall St. Rank hold LOGC as of Q1 2019.

Teachers Advisors held 10,888 shares of LogicBio Therapeutics, Inc. Common Stock worth $108K as of Q1 2019.
Teachers Advisors left its LogicBio Therapeutics, Inc. Common Stock share count unchanged in Q1 2019.
LogicBio Therapeutics, Inc. Common Stock made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2924 holding.
Teachers Advisors first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q4 2018 and has held it in 2 quarters since.
Teachers Advisors's LogicBio Therapeutics, Inc. Common Stock position peaked at $113K in Q4 2018.
33 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.